Cargando…

The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation

OBJECTIVE: The disease specific five-year survival rate especially for patients with advanced oral cancer has not improved significantly over the period of time. The most effective way of combating this dilemma is an early detection, diagnosis and eradication of early-stage lesions and their precurs...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanken, Henning, Kraatz, Juliane, Smeets, Ralf, Heiland, Max, Blessmann, Marco, Eichhorn, Wolfgang, Clauditz, Till Sebastian, Gröbe, Alexander, Kolk, Andreas, Rana, Madiha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851797/
https://www.ncbi.nlm.nih.gov/pubmed/23967796
http://dx.doi.org/10.1186/1746-160X-9-23
_version_ 1782294353334501376
author Hanken, Henning
Kraatz, Juliane
Smeets, Ralf
Heiland, Max
Blessmann, Marco
Eichhorn, Wolfgang
Clauditz, Till Sebastian
Gröbe, Alexander
Kolk, Andreas
Rana, Madiha
author_facet Hanken, Henning
Kraatz, Juliane
Smeets, Ralf
Heiland, Max
Blessmann, Marco
Eichhorn, Wolfgang
Clauditz, Till Sebastian
Gröbe, Alexander
Kolk, Andreas
Rana, Madiha
author_sort Hanken, Henning
collection PubMed
description OBJECTIVE: The disease specific five-year survival rate especially for patients with advanced oral cancer has not improved significantly over the period of time. The most effective way of combating this dilemma is an early detection, diagnosis and eradication of early-stage lesions and their precursors. The use of VELscope(®) using an autofluorescence as a diagnostic tool might be useful in early detection of oral malignant lesions. MATERIALS AND METHODS: 120 patients with suspicious oral premalignant lesions were examined with two examination methods. They were randomly divided into two groups. Group 1 was examined conventional with white-light and group 2 was examined additionally to the white-light-examination with an autofluorescence visualization device, VELscope(®). Biopsies were obtained from all suspicious areas identified in both examination groups (n = 52). The diagnostic strategies were compared regarding sensitivity and specificity. RESULTS: Based upon the result, use of the VELscope(®) leads to a higher sensitivity (22.0%), but regarding specificity the additional use of the VELscope(®) is inferior (8.4%). CONCLUSION: The VELscope device is a simple, non-invasive test of the oral mucosa, which can help the experienced clinician to find oral precursor malignant lesions.
format Online
Article
Text
id pubmed-3851797
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38517972013-12-06 The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation Hanken, Henning Kraatz, Juliane Smeets, Ralf Heiland, Max Blessmann, Marco Eichhorn, Wolfgang Clauditz, Till Sebastian Gröbe, Alexander Kolk, Andreas Rana, Madiha Head Face Med Research OBJECTIVE: The disease specific five-year survival rate especially for patients with advanced oral cancer has not improved significantly over the period of time. The most effective way of combating this dilemma is an early detection, diagnosis and eradication of early-stage lesions and their precursors. The use of VELscope(®) using an autofluorescence as a diagnostic tool might be useful in early detection of oral malignant lesions. MATERIALS AND METHODS: 120 patients with suspicious oral premalignant lesions were examined with two examination methods. They were randomly divided into two groups. Group 1 was examined conventional with white-light and group 2 was examined additionally to the white-light-examination with an autofluorescence visualization device, VELscope(®). Biopsies were obtained from all suspicious areas identified in both examination groups (n = 52). The diagnostic strategies were compared regarding sensitivity and specificity. RESULTS: Based upon the result, use of the VELscope(®) leads to a higher sensitivity (22.0%), but regarding specificity the additional use of the VELscope(®) is inferior (8.4%). CONCLUSION: The VELscope device is a simple, non-invasive test of the oral mucosa, which can help the experienced clinician to find oral precursor malignant lesions. BioMed Central 2013-08-23 /pmc/articles/PMC3851797/ /pubmed/23967796 http://dx.doi.org/10.1186/1746-160X-9-23 Text en Copyright © 2013 Hanken et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hanken, Henning
Kraatz, Juliane
Smeets, Ralf
Heiland, Max
Blessmann, Marco
Eichhorn, Wolfgang
Clauditz, Till Sebastian
Gröbe, Alexander
Kolk, Andreas
Rana, Madiha
The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation
title The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation
title_full The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation
title_fullStr The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation
title_full_unstemmed The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation
title_short The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscope(TM)) – a single blinded clinical evaluation
title_sort detection of oral pre- malignant lesions with an autofluorescence based imaging system (velscope(tm)) – a single blinded clinical evaluation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851797/
https://www.ncbi.nlm.nih.gov/pubmed/23967796
http://dx.doi.org/10.1186/1746-160X-9-23
work_keys_str_mv AT hankenhenning thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT kraatzjuliane thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT smeetsralf thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT heilandmax thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT blessmannmarco thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT eichhornwolfgang thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT clauditztillsebastian thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT grobealexander thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT kolkandreas thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT ranamadiha thedetectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT hankenhenning detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT kraatzjuliane detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT smeetsralf detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT heilandmax detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT blessmannmarco detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT eichhornwolfgang detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT clauditztillsebastian detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT grobealexander detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT kolkandreas detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation
AT ranamadiha detectionoforalpremalignantlesionswithanautofluorescencebasedimagingsystemvelscopetmasingleblindedclinicalevaluation